Chloé Wyndham-Thomas

969 total citations
31 papers, 423 citations indexed

About

Chloé Wyndham-Thomas is a scholar working on Infectious Diseases, Epidemiology and Health. According to data from OpenAlex, Chloé Wyndham-Thomas has authored 31 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 15 papers in Epidemiology and 10 papers in Health. Recurrent topics in Chloé Wyndham-Thomas's work include SARS-CoV-2 and COVID-19 Research (11 papers), Vaccine Coverage and Hesitancy (10 papers) and COVID-19 epidemiological studies (7 papers). Chloé Wyndham-Thomas is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (11 papers), Vaccine Coverage and Hesitancy (10 papers) and COVID-19 epidemiological studies (7 papers). Chloé Wyndham-Thomas collaborates with scholars based in Belgium, Italy and France. Chloé Wyndham-Thomas's co-authors include Toon Braeye, Laura Cornelissen, Herman Van Oyen, Lucy Catteau, Naïma Hammami, Violette Dirix, Joris Adriaan Frank van Loenhout, Françoise Mascart, Ruben Brondeel and Veerle Stouten and has published in prestigious journals such as The Lancet Infectious Diseases, Journal of Leukocyte Biology and BMC Public Health.

In The Last Decade

Chloé Wyndham-Thomas

29 papers receiving 417 citations

Peers

Countries citing papers authored by Chloé Wyndham-Thomas

Since Specialization

Citations

This map shows the geographic impact of Chloé Wyndham-Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chloé Wyndham-Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chloé Wyndham-Thomas more than expected).

Fields of papers citing papers by Chloé Wyndham-Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chloé Wyndham-Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chloé Wyndham-Thomas. The network helps show where Chloé Wyndham-Thomas may publish in the future.

Co-authorship network of co-authors of Chloé Wyndham-Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Chloé Wyndham-Thomas. A scholar is included among the top collaborators of Chloé Wyndham-Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chloé Wyndham-Thomas. Chloé Wyndham-Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effectiveness of the AZD1222 vaccine against COVID-19 hospitalization in Europe: final results from the COVIDRIVE test-negative case–control study 2025 ·European Journal of Public Health ·Leonie de Munter, Wilhelmine Meeraus, (unknown), (unknown), Chloé Wyndham-Thomas, Lucy Carty, Mario Ouwens, (unknown), Laura Drikite, (unknown), Irma Casas, Ainara Mira‐Iglesias, Giancarlo Icardi, Susana Otero-Romero, (unknown), Charlotte Martin, Xavier Holemans, Gerrit L. ten Kate, Kaatje Bollaerts, Sylvia Taylor	0
2	Strategies for introducing and implementing vaccines for adults into national immunization programs in Europe: Good practices and key insights of the adult immunization board meeting 2025 ·Human Vaccines & Immunotherapeutics ·Sara Boccalini, Angela Bechini, Marco Del Riccio, Birgit Weinberger, Jacek Wysocki, Domenico Martinelli, Ole Wichmann, (unknown), Greet Hendrickx, Pierre Van Damme, Chloé Wyndham-Thomas, Paolo Bonanni, Jade Pattyn	1
3	The role of real-world evidence for regulatory and public health decision-making for Accelerated Vaccine Deployment- a meeting report 2024 ·Biologicals ·Kaatje Bollaerts, Chloé Wyndham-Thomas, Elizabeth Miller, Héctor S. Izurieta, Steve Black, Nick Andrews, (unknown), Fran Van Heuverswyn, Pieter Neels	13
4	Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022 2023 ·Vaccine ·Toon Braeye, Lucy Catteau, Ruben Brondeel, Joris Adriaan Frank van Loenhout, (unknown), Laura Cornelissen, Herman Van Oyen, Veerle Stouten, (unknown), (unknown), (unknown), Romain Mahieu, Naïma Hammami, Dieter Van Cauteren, Chloé Wyndham-Thomas	26
5	Sociodemographic and socioeconomic disparities in COVID-19 vaccine uptake in Belgium: a nationwide record linkage study 2023 ·Journal of Epidemiology & Community Health ·(unknown), Joris Adriaan Frank van Loenhout, Brecht Devleesschauwer, Chloé Wyndham-Thomas, Herman Van Oyen, (unknown), Koen Blot, Laura Van den Borre, (unknown), Niko Speybroeck, Robby De Pauw, Veerle Stouten, Lucy Catteau, (unknown)	11
6	Protection against COVID-19 hospitalisation conferred by primary-series vaccination with AZD1222 in non-boosted individuals: first vaccine effectiveness results of the European COVIDRIVE study and meta-regression analysis 2023 ·The Lancet Regional Health - Europe ·Wilhelmine Meeraus, Leonie de Munter, Christen M. Gray, (unknown), Chloé Wyndham-Thomas, Mario Ouwens, (unknown), Laura Drikite, (unknown), (unknown), Anke L. Stuurman, (unknown), Guillermo Mena, Ainara Mira‐Iglesias, Giancarlo Icardi, Susana Otero‐Romero, (unknown), Charlotte Martin, Sylvia Taylor, Kaatje Bollaerts	2
7	Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021 2022 ·Vaccine ·Toon Braeye, Lucy Catteau, Ruben Brondeel, Joris Adriaan Frank van Loenhout, (unknown), Laura Cornelissen, Herman Van Oyen, Veerle Stouten, (unknown), (unknown), (unknown), Romain Mahieu, Naïma Hammami, Dieter Van Cauteren, Chloé Wyndham-Thomas	15
8	Vaccine effectiveness against infection and onwards transmission of COVID-19: Analysis of Belgian contact tracing data, January-June 2021 2021 ·Vaccine ·Toon Braeye, Laura Cornelissen, Lucy Catteau, (unknown), (unknown), Karin De Ridder, (unknown), Romain Mahieu, (unknown), (unknown), Naïma Hammami, Sophie Quoilin, Herman Van Oyen, Chloé Wyndham-Thomas, Dieter Van Cauteren	30
9	Conceptual causal framework to assess the effect of SARS-CoV-2 variants on COVID-19 disease severity among hospitalized patients 2021 ·Archives of Public Health ·Nina Van Goethem, (unknown), (unknown), Chloé Wyndham-Thomas, Lucy Catteau, Ruben Brondeel, Sofieke Klamer, (unknown), Lize Cuypers, Emmanuel André, Koen Blot, Herman Van Oyen	12
10	Incidence rate, predictors and outcomes of interruption of HIV care: nationwide results from the Belgian HIV cohort 2020 ·HIV Medicine ·Dominique Van Beckhoven, Éric Florence, Stéphane De Wit, Chloé Wyndham-Thomas, André Deeke Sasse, Herman Van Oyen, Jean Macq	11
11	Dynamic changes in paediatric invasive pneumococcal disease after sequential switches of conjugate vaccine in Belgium: a national retrospective observational study 2020 ·The Lancet Infectious Diseases ·Stefanie Desmet, Katrien Lagrou, Chloé Wyndham-Thomas, Toon Braeye, Jan Verhaegen, Piet Maes, Steffen Fieuws, Willy Peetermans, Sophie Blumental	51
12	Rapid establishment of a national surveillance of COVID-19 hospitalizations in Belgium 2020 ·Archives of Public Health ·Nina Van Goethem, (unknown), Chloé Wyndham-Thomas, Jessika Deblonde, Nathalie Bossuyt, Tinne Lernout, (unknown), Sophie Quoilin, (unknown), Dominique Van Beckhoven	30
13	Asymptomatic SARS-CoV-2 infection in Belgian long-term care facilities 2020 ·The Lancet Infectious Diseases ·Ana Hoxha, Chloé Wyndham-Thomas, Sofieke Klamer, Dominique Dubourg, Melissa Vermeulen, Naïma Hammami, Laura Cornelissen	34
14	Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up 2019 ·BMC Public Health ·(unknown), Vanessa Suin, Chloé Wyndham-Thomas, Sophie Quoilin, Gaëtan Muyldermans, Thomas Vanwolleghem, Benoît Kabamba‐Mukadi, (unknown), (unknown), Steven Van Gucht, Veronik Hutse	16
15	Prospective Serial FDG PET/CT During Treatment of Extrapulmonary Tuberculosis in HIV-Infected Patients 2018 ·Clinical Nuclear Medicine ·Charlotte Martin, Cathérine Castaigne, (unknown), (unknown), Chloé Wyndham-Thomas, Christoph Stephan	12
16	Response of Human Immunodeficiency Virus-Associated Cerebral Angiitis to the Combined Antiretroviral Therapy 2017 ·Frontiers in Neurology ·Julian Chéron, Chloé Wyndham-Thomas, Niloufar Sadeghi, Gilles Naeije	6
17	Le Diable dans la peau ? 2017 ·La Revue de Médecine Interne ·(unknown), R. Damade, (unknown), Jean‐David Bouaziz, Chloé Wyndham-Thomas	1
18	Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON®-TB Gold In-tube 2015 ·BMC Infectious Diseases ·Chloé Wyndham-Thomas, Violette Dirix, Kinda Schepers, Charlotte Martin, (unknown), Jean‐Christophe Goffard, F. Domont, Myriam Libin, Marc Loyens, Camille Locht, Jean‐Paul Van Vooren, Françoise Mascart	14
19	Key Role of Effector Memory CD4⁺T Lymphocytes in a Short-Incubation Heparin-Binding Hemagglutinin Gamma Interferon Release Assay for the Detection of Latent Tuberculosis 2014 ·Clinical and Vaccine Immunology ·Chloé Wyndham-Thomas, Véronique Corbière, Violette Dirix, (unknown), F. Domont, Myriam Libin, Marc Loyens, Camille Locht, Françoise Mascart	27
20	BARRIERS TO LIVER TRANSPLANTATION IN HIV INFECTED PATIENTS 2013 ·Acta Clinica Belgica ·Chloé Wyndham-Thomas, Marc Delforge, (unknown), Stéphane De Wit	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact